Penn Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,613
| Closed | -$2.15M | – | 164 |
|
|
2023
Q4 | $2.15M | Sell |
9,613
-621
| -6% | -$139K | 0.2% | 98 |
|
|
2023
Q3 | $2.35M | Sell |
10,234
-63
| -0.6% | -$14.4K | 0.24% | 99 |
|
|
2023
Q2 | $2.27M | Buy |
10,297
+16
| +0.2% | +$3.53K | 0.22% | 101 |
|
|
2023
Q1 | $2.36M | Sell |
10,281
-1,045
| -9% | -$240K | 0.24% | 100 |
|
|
2022
Q4 | $3.2M | Buy |
11,326
+596
| +6% | +$168K | 0.33% | 81 |
|
|
2022
Q3 | $2.29M | Buy |
10,730
+1,838
| +21% | +$391K | 0.26% | 99 |
|
|
2022
Q2 | $2.1M | Buy |
8,892
+932
| +12% | +$220K | 0.23% | 105 |
|
|
2022
Q1 | $1.43M | Sell |
7,960
-416
| -5% | -$74.9K | 0.15% | 149 |
|
|
2021
Q4 | $1.76M | Sell |
8,376
-316
| -4% | -$66.2K | 0.18% | 146 |
|
|
2021
Q3 | $1.6M | Buy |
8,692
+84
| +1% | +$15.5K | 0.16% | 152 |
|
|
2021
Q2 | $1.54M | Buy |
+8,608
| New | +$1.54M | 0.15% | 162 |
|